Micro RNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR
Luminal A breast cancer usually responds to hormonal therapies but does not benefit from chemotherapies, including microtubule-targeted paclitaxel. MicroRNAs could play a role in mediating this differential response. In this study, we examined the role of micro RNA 100 (miR-100) in the sensitivity o...
Saved in:
Published in | Oncotarget Vol. 7; no. 5; pp. 5702 - 5714 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Impact Journals LLC
02.02.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!